Segment Information by Division

For the Period January 1 to December 31

2013

  Download XLS

 

  

 

€ million

  

Silicones

  

Polymers

  

Bio- solutions

  

Polysilicon

  

Siltronic

  

Other

  

Con­solidation

  

Group

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

1

Intangible assets; property, plant and equipment; investment property

2

Investments in joint ventures and associates, financial assets

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 22.

External sales

  

1,672.0

  

958.3

  

158.4

  

844.9

  

735.8

  

109.5

  

–

  

4,478.9

Internal sales

  

0.2

  

20.4

  

–

  

79.3

  

7.2

  

83.2

  

-190.3

  

–

Total sales

  

1,672.2

  

978.7

  

158.4

  

924.2

  

743.0

  

192.7

  

-190.3

  

4,478.9

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT

  

151.1

  

112.9

  

17.2

  

0.1

  

-95.9

  

-73.1

  

2.0

  

114.3

Depreciation and impairments/write-ups

  

79.1

  

34.9

  

6.4

  

233.8

  

122.4

  

87.8

  

–

  

564.4

EBITDA

  

230.2

  

147.8

  

23.6

  

233.9

  

26.5

  

14.7

  

2.0

  

678.7

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT includes:

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Result from investments in joint ventures and associates

  

5.9

  

–

  

–

  

–

  

-42.5

  

–

  

0.5

  

-36.1

Impairment losses

  

–

  

–

  

–

  

-1.4

  

-34.8

  

-0.8

  

–

  

-37.0

Additions to property, plant and equipment1

  

85.4

  

36.8

  

10.2

  

290.0

  

30.9

  

50.4

  

–

  

503.7

Additions to financial assets2

  

–

  

–

  

–

  

–

  

–

  

–

  

–

  

–

Asset additions

  

85.4

  

36.8

  

10.2

  

290.0

  

30.9

  

50.4

  

–

  

503.7

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Assets (Dec. 31)

  

1,186.9

  

481.2

  

116.1

  

2,331.9

  

1,095.6

  

1,500.4

  

-379.7

  

6,332.4

Liabilities (Dec. 31)

  

691.8

  

280.6

  

60.7

  

1,809.4

  

302.8

  

1,365.4

  

-375.4

  

4,135.3

Net assets (Dec. 31)

  

495.1

  

200.6

  

55.4

  

522.5

  

792.8

  

135.0

  

-4.3

  

2,197.1

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Investments in joint ventures and associates included in net assets
(Dec. 31)

  

18.9

  

–

  

–

  

–

  

–

  

–

  

–

  

18.9

Research and development expenses

  

34.6

  

12.3

  

7.0

  

20.6

  

59.2

  

43.4

  

-3.3

  

173.8

Employees (Dec. 31)

  

4,109

  

1,377

  

371

  

2,102

  

3,746

  

4,304

  

–

  

16,009

Employees (average)

  

4,110

  

1,377

  

371

  

2,126

  

3,806

  

4,344

  

–

  

16,134

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

2012*

  Download XLS

 

  

 

€ million

  

Silicones

  

Polymers

  

Bio- solutions

  

Polysilicon

  

Siltronic

  

Other

  

Con­solidation

  

Group

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

1

Intangible assets; property, plant and equipment; investment property

2

Investments in joint ventures and associates, financial assets

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 22.

*

Adjusted for the effects of the adoption of IAS 19 (revised); see Changes in Accounting and Valuation Methods in the Notes section.

External sales

  

1,633.8

  

975.3

  

154.1

  

949.4

  

858.5

  

63.8

  

–

  

4,634.9

Internal sales

  

14.2

  

27.8

  

3.5

  

186.4

  

9.4

  

106.1

  

-347.4

  

–

Total sales

  

1,648.0

  

1,003.1

  

157.6

  

1,135.8

  

867.9

  

169.9

  

-347.4

  

4,634.9

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT

  

106.4

  

110.7

  

17.8

  

200.8

  

-92.2

  

-76.8

  

-0.1

  

266.6

Depreciation and impairments/write-ups

  

82.9

  

36.7

  

6.7

  

226.7

  

92.9

  

82.9

  

–

  

528.8

EBITDA

  

189.3

  

147.4

  

24.5

  

427.5

  

0.7

  

6.1

  

-0.1

  

795.4

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT includes:

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Result from investments in joint ventures and associates

  

-55.9

  

–

  

–

  

–

  

-26.6

  

–

  

-0.1

  

-82.6

Impairment losses

  

–

  

–

  

–

  

–

  

-2.5

  

–

  

–

  

-2.5

Additions to property, plant and equipment1

  

70.9

  

58.8

  

19.3

  

698.1

  

73.3

  

56.9

  

–

  

977.3

Additions to financial assets2

  

87.9

  

–

  

–

  

–

  

29.9

  

0.3

  

–

  

118.1

Asset additions

  

158.8

  

58.8

  

19.3

  

698.1

  

103.2

  

57.2

  

–

  

1,095.4

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Assets (Dec. 31)

  

1,174.6

  

483.2

  

107.6

  

2,417.6

  

1,136.6

  

1,446.3

  

-273.1

  

6,492.8

Liabilities (Dec. 31)

  

691.2

  

265.4

  

55.8

  

1,996.8

  

385.6

  

1,240.2

  

-263.5

  

4,371.5

Net assets (Dec. 31)

  

483.4

  

217.8

  

51.8

  

420.8

  

751.0

  

206.1

  

-9.6

  

2,121.3

Investments in joint ventures and associates included in net assets (Dec. 31)

  

19.3

  

–

  

–

  

–

  

22.2

  

–

  

-0.5

  

41.0

Research and development expenses

  

31.3

  

13.0

  

6.6

  

12.8

  

67.4

  

47.6

  

-5.0

  

173.7

Employees (Dec. 31)

  

3,960

  

1,365

  

357

  

2,349

  

3,978

  

4,283

  

–

  

16,292

Employees (average)

  

3,947

  

1,370

  

349

  

2,325

  

4,351

  

4,321

  

–

  

16,663